SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-622589
Filing Date
2016-06-15
Accepted
2016-06-15 16:59:51
Documents
53
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d192920d10q.htm 10-Q 606571
2 EX-31.1 d192920dex311.htm EX-31.1 8582
3 EX-31.2 d192920dex312.htm EX-31.2 8578
4 EX-32.1 d192920dex321.htm EX-32.1 5501
  Complete submission text file 0001193125-16-622589.txt   2938527

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20160331.xml EX-101.INS 384689
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20160331.xsd EX-101.SCH 33021
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20160331_cal.xml EX-101.CAL 44605
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20160331_def.xml EX-101.DEF 136344
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20160331_lab.xml EX-101.LAB 299336
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20160331_pre.xml EX-101.PRE 224685
Mailing Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757
Business Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757 508-473-5993
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 161715819
SIC: 2834 Pharmaceutical Preparations